Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL

NCT00151320

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Nebraska Medical Center Omaha, Nebraska, United States
  • Weill Medical College of Cornell University New York, United States
  • Columbia University College of Physicians and Surgeons New York, United States
View Trial Details
Completed

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma

NCT00389818

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

NCT00911105

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Onkologische Schwerpunktpraxis Bad Homburg, Germany
  • Onkologische Schwerpunktpraxis Berlin, Germany
  • Onkologisches Versorgungszentrum Friedrichshain Berlin, Germany
  • Onkologische Praxis Berlin, Germany
View all 20 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

NCT00392834

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • UCSF Medical Center at Parnassus San Francisco, California, United States
View all 13 locations
View Trial Details

Related conditions